Publicacions en col·laboració amb investigadors/es de Hospital de la Santa Creu i Sant Pau (16)

2022

  1. Neuroblastoma in Spain: Linking the national clinical database and epidemiological registries – A study by the Joint Action on Rare Cancers

    Cancer Epidemiology, Vol. 78

2021

  1. Next-generation Sequencing in Bone Marrow Failure Syndromes and Isolated Cytopenias: Experience of the Spanish Network on Bone Marrow Failure Syndromes

    HemaSphere, Vol. 5, Núm. 4

2020

  1. Initial report on Spanish pediatric oncologic, hematologic, and post stem cell transplantation patients during SARS-CoV-2 pandemic

    Pediatric Blood and Cancer

2011

  1. Chromosome fragility in patients with Fanconi anaemia: Diagnostic implications and clinical impact

    Journal of Medical Genetics, Vol. 48, Núm. 4, pp. 242-250

  2. Guidelines for the treatment of invasive fungal disease by Aspergillus spp. and other fungi issued by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2011 Update

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. 6, pp. 435-454

  3. Origin, functional role, and clinical impact of fanconi anemia fanca mutations

    Blood, Vol. 117, Núm. 14, pp. 3759-3769

  4. Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC) guidelines for the diagnosis of invasive fungal infections. 2010 Update

    Enfermedades Infecciosas y Microbiologia Clinica

2009

  1. Lentiviral-mediated genetic correction of hematopoietic and mesenchymal progenitor cells from fanconi anemia patients

    Molecular Therapy, Vol. 17, Núm. 6, pp. 1083-1092

2006

  1. A simplified approach to improve the efficiency and safety of ex vivo hematopoietic gene therapy in fanconi anemia patients

    Human Gene Therapy, Vol. 17, Núm. 2, pp. 245-250

2005

  1. Long-term outcome of allogeneic PBSC transplantation in pediatric patients with hematological malignancies: A report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON) and the Spanish Group for Allogeneic Peripheral Blood Transplantation (GETH)

    Bone Marrow Transplantation, Vol. 36, Núm. 9, pp. 781-785

2004

  1. Risk assessment and outcome of chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell transplantation in pediatric patients

    Bone Marrow Transplantation, Vol. 34, Núm. 5, pp. 433-438

2002

  1. Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia

    Blood, Vol. 100, Núm. 12, pp. 3877-3886

  2. Matched-pair analysis comparing allogeneic PBPCT and BMT from HLA-identical relatives in childhood acute lymphoblastic leukemia

    Bone Marrow Transplantation, Vol. 30, Núm. 1, pp. 9-13

2000

  1. Trasplante de progenitores hematopoyéticos de sangre de cordón umbilical en niños

    Anales Espanoles de Pediatria, Vol. 53, Núm. 6, pp. 513-519

1999

  1. Recombinant human granulocyte-macrophage colony-stimulating factor accelerates engraftment kinetics after allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia

    Haematologica, Vol. 84, Núm. 2, pp. 133-137

  2. Trasplante alogenico de medula osea en ninos con aplasia medular grave adquirida. Resultados a largo plazo

    Anales Espanoles de Pediatria, Vol. 50, Núm. 1, pp. 29-32